Researchers reported efficacy and safety data through 48 months of continuous pegcetacoplan treatment across OAKS, DERBY and ...

Investigators crafted a classification for age-related macular degeneration (AMD) based on optical coherence tomography (OCT) ...

Investigators evaluated the clinical benefit of a sustained‐release dexamethasone intravitreal implant as a second‐line ...

Investigators reviewed the application of micropulse laser therapy in addition to aflibercept injections in patients with ...

Investigators reviewed a large electronic health records database to evaluate the association between varicose veins and CSCR ...

Identifying the correct uveitis type can help reveal underlying systemic infections, neoplastic conditions, and other ...

A preservative-free LUMIFY® is statistically equivalent to the BAK-containing formulation in managing ocular redness.

After months with an appointed caretaker, the US Centers for Disease Control and Prevention (CDC) finally has an official director.

Researchers tested more than 65,000 patients with more than 30 solid tumor types and found the rate of HER2 positivity was about 3%.

Two inflammatory tear fluid biomarkers may serve a diagnostic purpose in thyroid eye disease, according to a cross-sectional study.

Faricimab, compared with aflibercept, reduces the risk of epiretinal membrane formation in eyes with diabetic macular edema, research shows.

Living near green spaces before and during pregnancy, as well as in early childhood, may lower the risk for neurodevelopmental disorders.